Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19
Additional Info
- Business Line: Hemostasis
- Clinical Area: COVID-19
- Author(s): Claire S WhyteGael B MorrowJoanne L MitchellPratima ChowdaryNicola J Mutch
- Year: 2020
- Pubmed: Read More